THE US FDA is examining the potential misuse and abuse of gabapentinoids: gabapentin pregabalin. These drugs are increasingly used for the management of various neuropathic pain conditions. Trending data suggest possible patterns consistent with abuse of these drugs. As the prevalence of prescribing increases worldwide, concern as been expressed regarding potential for tolerance and dependence, as well as withdrawal reactions. Refer for a patient-oriented resource